The role of TSH receptor antibodies in the management of Graves' disease
- 30 June 2011
- journal article
- case report
- Published by Elsevier BV in European Journal of Internal Medicine
- Vol. 22 (3), 213-216
- https://doi.org/10.1016/j.ejim.2011.02.006
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The role of imaging in Graves’ disease: A cost-effectiveness analysisEuropean Journal of Radiology, 2008
- D. Thyroid Autoantibodies (TPOAb, TgAb and TRAb)Thyroid®, 2003
- A monoclonal thyroid-stimulating antibodyJCI Insight, 2002
- TSH‐receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assaysClinical Endocrinology, 2001
- Graves' diseaseThe Lancet, 2001
- Graves' DiseaseNew England Journal of Medicine, 2000
- Thyroid-Stimulating Antibodies Predict HyperthyroidismaJournal of Clinical Endocrinology & Metabolism, 1998
- TSH Receptor Antibody Measurement in the Diagnosis and Management of Graves' Disease Is Rarely NecessarybJournal of Clinical Endocrinology & Metabolism, 1998
- Thyroid-Stimulating Antibodies Predict HyperthyroidismaJournal of Clinical Endocrinology & Metabolism, 1998
- VALUE OF THYROID-STIMULATING-ANTIBODY DETERMINATIONS IN PREDICTING SHORT-TERM THYROTOXIC RELAPSE IN GRAVES' DISEASEThe Lancet, 1977